Revital Shamri

1.4k citations
19 papers · 1.1k indexed · h-index 13

Revital Shamri

19 papers receiving 1.1k citations

Peers

Revital Shamri
Comparison fields: 5 of 88
  • Immunology and Allergy 550
  • Immunology 577
  • Hematology 172
  • Cell Biology 155
  • Physiology 148
Replace Philippe Frachet with:
Philippe Frachet France
Alan R. Schenkel United States
M J Metzelaar Netherlands
L Strockbine United States
S. Kent Dickeson United States
Louise M. C. Webb United Kingdom
Gerben Bouma United Kingdom
Marita Bosticardo Italy
P. A. T. Tetteroo Netherlands
Fujiko Kitamura Japan
Revital Shamri relative to Philippe Frachet France Philippe Frachet's profile →
Citations per field
00.5×1.5×1.8×
Philippe Frachet · 1×
Citations per year

Countries citing papers authored by Revital Shamri

Since Specialization
Citations

This map shows the geographic impact of Revital Shamri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Revital Shamri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Revital Shamri more than expected).

Fields of papers citing papers by Revital Shamri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Revital Shamri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Revital Shamri. The network helps show where Revital Shamri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Revital Shamri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Revital Shamri Line = papers co-authored together Revital Shamri links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20191
2 201823
3 20183
4 201510
5 201411
6 201331
7 201241
8 201216
9 2010173
10 200828
11
Pasvolsky, R. et al. RhoA is involved in LFA-1 extension triggered by CXCL12 but not in a novel outside-in LFA-1 activation facilitated by CXCL9. J. Immunol. 180, 2815-2823
20086
12 20075
13 2005301
14 200488
15 200375
16 200368
17 200377
18 200247
19 200183

About Revital Shamri

Revital Shamri is a scholar working on Immunology and Allergy, Hematology and Microbiology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (10 papers), Platelet Disorders and Treatments (7 papers), Asthma and respiratory diseases (7 papers), Eosinophilic Disorders and Syndromes (4 papers), Antimicrobial Peptides and Activities (3 papers), Immune Cell Function and Interaction (3 papers), Immune Response and Inflammation (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Immunology and Allergy (550 citations), Immunology (577 citations) and Hematology (172 citations). Revital Shamri has collaborated with scholars based in United States, Israel and Brazil. Frequent co-authors include R. Alon, Valentin Grabovsky, Sara W. Feigelson, Lisa A. Spencer, Jason Xenakis, Guy Cinamon, Donald E. Staunton, Jean-Marc Gauguet, Ulrich H. von Andrian and Martyn K. Robinson.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026